Articles from Linnaeus Therapeutics

Linnaeus Therapeutics Awarded Up to $22 Million from ARPA-H to Advance LNS8801 for Healthspan Preservation
ARPA-H PROSPR program to support accelerated development of LNS8801 to promote healthy aging
By Linnaeus Therapeutics · Via GlobeNewswire · February 24, 2026